SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $336 | -68.0% | 559,731 | -30.6% | 0.03% | -72.4% |
Q2 2023 | $1,049 | +171.8% | 806,954 | +268.3% | 0.10% | +176.3% |
Q1 2023 | $386 | -38.6% | 219,088 | +9.3% | 0.04% | -51.3% |
Q4 2022 | $629 | -99.2% | 200,465 | +1232.0% | 0.08% | +680.0% |
Q3 2022 | $74,000 | -21.3% | 15,050 | -33.9% | 0.01% | -28.6% |
Q2 2022 | $94,000 | -55.0% | 22,785 | -36.7% | 0.01% | -50.0% |
Q1 2022 | $209,000 | -27.9% | 35,978 | +11.6% | 0.03% | -6.7% |
Q3 2021 | $290,000 | +215.2% | 32,240 | +215.4% | 0.03% | -41.2% |
Q2 2020 | $92,000 | +8.2% | 10,223 | +0.3% | 0.05% | +410.0% |
Q4 2019 | $85,000 | -86.3% | 10,189 | -84.3% | 0.01% | -84.1% |
Q1 2019 | $620,000 | -31.3% | 65,031 | -17.3% | 0.06% | -39.4% |
Q4 2018 | $902,000 | +104.5% | 78,600 | +238.5% | 0.10% | +352.2% |
Q1 2018 | $441,000 | -55.8% | 23,221 | -63.5% | 0.02% | -42.5% |
Q1 2015 | $997,000 | +261.2% | 63,576 | +316.9% | 0.04% | +100.0% |
Q1 2014 | $276,000 | – | 15,249 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |